Jasper Therapeutics Inc. (JSPR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 09-2024 | 06-2024 | 03-2024 | 12-2023 | 09-2023 | |
| Operating Expenses | 19,889 | 15,993 | 15,072 | 17,725 | 19,362 |
| Operating Income | -19,889 | -15,993 | -15,072 | -17,725 | -19,362 |
| Other Income | 1,252 | 1,410 | 1,344 | 1,144 | 1,818 |
| Pre-tax Income | -18,637 | -14,583 | -13,728 | -16,581 | -17,544 |
| Net Income Continuous | -18,637 | -14,583 | -13,728 | -16,581 | -17,544 |
| Net Income | $-18,637 | $-14,583 | $-13,728 | $-16,581 | $-17,544 |
| EPS Basic Total Ops | -1.24 | -0.97 | -1.03 | -1.49 | -1.60 |
| EPS Basic Continuous Ops | -1.24 | -0.97 | -1.03 | -1.48 | -1.60 |
| EPS Diluted Total Ops | -1.24 | -0.97 | -1.03 | -1.49 | -1.60 |
| EPS Diluted Continuous Ops | -1.24 | -0.97 | -1.03 | -1.48 | -1.60 |
| EPS Diluted Before Non-Recurring Items | -1.24 | -0.97 | -1.03 | N/A | N/A |
| EBITDA(a) | $-19,348 | $-15,694 | $-14,784 | $-17,442 | $-19,086 |